Augmentin Dosing in CKD Stage 3
For adults with CKD stage 3 (eGFR 30-59 mL/min/1.73 m²), use standard Augmentin dosing without adjustment, but monitor closely for adverse effects related to clavulanic acid accumulation.
Dosing Algorithm
Step 1: Determine Exact eGFR Category
- CKD 3a (eGFR 45-59 mL/min): Use standard adult dosing
- CKD 3b (eGFR 30-44 mL/min): Use standard adult dosing with caution
Step 2: Select Appropriate Formulation and Dose
For typical infections in adults:
- Augmentin 500/125 mg PO every 12 hours (moderate infections)
- Augmentin 875/125 mg PO every 12 hours (more severe infections)
Do NOT reduce the dose in CKD stage 3 1.
Step 3: Key Monitoring Parameters
Monitor for:
- Gastrointestinal side effects (nausea, diarrhea) - clavulanic acid accumulates more than amoxicillin
- Hepatic function - clavulanate can cause hepatotoxicity
- Clinical response within 48-72 hours
Critical Pharmacokinetic Considerations
The evidence reveals a crucial asymmetry in how renal impairment affects the two components of Augmentin 2:
- Amoxicillin clearance decreases substantially with declining renal function
- Clavulanic acid clearance decreases less dramatically due to significant non-renal metabolism
This differential effect means that in CKD stage 3, the amoxicillin-to-clavulanic acid ratio remains relatively balanced (approximately 5:1), similar to normal renal function 2. The ratio only becomes problematic (>10:1) when eGFR drops below 30 mL/min.
When to Adjust Dosing
Dose adjustment becomes necessary only when eGFR falls below 30 mL/min (CKD stages 4-5):
- eGFR 10-30 mL/min: Reduce to 500/125 mg every 12-24 hours OR 250/125 mg every 12 hours
- eGFR <10 mL/min: 500/125 mg every 24 hours OR 250/125 mg every 12 hours
- Hemodialysis: 500/125 mg every 24 hours, with supplemental dose after dialysis 2
Important Caveats
Avoid Common Prescribing Errors
- Do not prematurely reduce doses in CKD stage 3 - this is a frequent error that leads to therapeutic failure 3, 4
- Different formulations are NOT interchangeable - Augmentin ES-600 suspension contains different clavulanic acid ratios and should not be substituted 1
- Take with food - administer at the start of meals to minimize GI intolerance and enhance clavulanic acid absorption 1
Special Populations
- Hepatic impairment: Use with extreme caution and monitor liver function regularly, as clavulanic acid can cause cholestatic jaundice 1
- Elderly patients: While no specific dose adjustment is needed for age alone, ensure accurate eGFR calculation (not just serum creatinine) as elderly patients often have reduced muscle mass 5, 6
Acute Kidney Injury Overlay
If the patient has acute kidney injury (AKI) superimposed on CKD stage 3, consider deferring dose reduction for the first 48 hours of therapy, as AKI often resolves quickly and premature dose reduction may lead to subtherapeutic levels 7. However, this applies primarily to antibiotics with wide therapeutic indices and should be individualized based on infection severity.
Guideline Context
The KDIGO 2024 guidelines emphasize that eGFR-based dosing is appropriate for most clinical settings 8, and the 2014 KDOQI commentary specifically notes that penicillins (including amoxicillin/clavulanate) require dose adjustment primarily when eGFR drops below 30 mL/min 3. The FDA label for Augmentin does not specify dose reductions for CKD stage 3 1, which aligns with the pharmacokinetic data showing preserved drug ratios at this level of renal function 2.